GSK4388067A

N/A

Report date: 2026/05/07 20:00:36

Base Information

Drug NameGSK4388067A

Drug Alias NameGSK-4388067-A

ClassificationBiologics > Protein drugs > Recombinant proteinSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHepatitis B, Chronic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc

Inactive CompaniesN/A

Active IndicationsHepatitis B, Chronic

Inactive IndicationsN/A

Other Information

ATC CodeN/A